Results 161 to 170 of about 4,756,303 (211)

Recurrent Primary Effusion Lymphoma [PDF]

, 2020
openaire   +1 more source

Primary effusion lymphoma with biphenotypic and bigenotypic features of T-cell receptor and IGH genes in an HIV-negative patient with kidney transplant. [PDF]

Ann Hematol
Jeon T, Ko YH, Sung YN, Kim H, Kang KW, Sim JM, Kim Y.   +6 more
europepmc   +1 more source

Extracavitary Primary Effusion Lymphoma [PDF]

, 2020
openaire   +1 more source

HIV-positive and HHV-8-negative primary effusion lymphoma complicated with coronary heart disease: a Case Report and literature review. [PDF]

Front Med (Lausanne)
Zhang W, Zhang Y, Yuan J.
europepmc   +1 more source

An Unusual Case of Extracavitary/Solid Variant Primary Effusion Lymphoma With Associated Hemophagocytic Lymphohistiocytosis. [PDF]

J Med Cases
Iguh C, Kim J, Akaraonye A, Minja A, Qing X.   +4 more
europepmc   +1 more source

Inhibiting HSP27 activates the XBP1s/CerS1 interplay, which triggers DRP1-driven mitophagy, thereby protecting against cell death and promoting the KSHV lytic cycle in primary effusion lymphoma cells. [PDF]

Cell Death Discov
Gonnella R, Corrado V, Scaffidi GF, Benedetti R, Di Crosta M, Zarrella R, Gilardini Montani MS, Santarelli R, Cirone M.   +8 more
europepmc   +1 more source

LKB1 suppresses KSHV reactivation and promotes primary effusion lymphoma progression. [PDF]

J Virol
Li G, Li Y, Tang X, Wang L, Yue S, He S, Li T.   +6 more
europepmc   +1 more source

Identification of RP-54745, an IL-1 Inhibitor Displaying Anticancer Activities for KSHV-Related Primary Effusion Lymphoma. [PDF]

J Med Virol
Dai L, Choudhary A, Fan J, Huang L, Lin Z, Qin Z.   +5 more
europepmc   +1 more source

Primary Effusion Lymphoma in an HIV-Negative Patient with Chronic Myeloid Leukemia Treated with Dasatinib.

Pathobiology, 2023
SahBandar IN, Sy CB, van den Akker T, Kim D, Geyer JT, Chadburn A, Cesarman E, Inghirami G, Allan JN, Siddiqui MT, Ouseph MM.   +10 more
europepmc   +1 more source

Repurposing alcohol-abuse drug disulfiram for the treatment of KSHV-infected primary effusion lymphoma by activating antiviral innate immunity. [PDF]

PLoS Pathog
Wang L, Liu Z, Xu Z, Wang W, Yang J, Zhang J, He S, Liang Q, Li T.   +8 more
europepmc   +1 more source